Amylyx Pharmaceuticals (AMLX) Price to FCF (2022 - 2026)

Amylyx Pharmaceuticals has reported Price to FCF for 5 years, with the latest figure at 63.65 in Q2 2026.

• On a quarterly basis, Price to FCF fell 181.39% year-over-year to 63.65 in Q2 2026; TTM through Jun 2026 was 15.79, a 357.71% decrease from a year earlier, with the FY2025 full-year figure at 10.75, down 595.35% from the prior year.
• Price to FCF was 63.65 for Q2 2026 at Amylyx Pharmaceuticals, down from 41.84 in the prior quarter.
• The five-year high for Price to FCF was 174.39 in Q2 2023, with the low at 369.9 in Q1 2023.
• Average Price to FCF over 5 years is 59.09, with a median of 30.77 recorded in 2022.
• The largest YoY upside for Price to FCF was 835.81% in 2023 against a maximum downside of 1938.43% in 2023.
• Over 5 years, Price to FCF stood at 48.84 in 2022, then jumped by 254.64% to 75.53 in 2023, then slumped by 105.82% to 4.39 in 2024, then sank by 979.12% to 47.43 in 2025, then tumbled by 34.21% to 63.65 in 2026.
• The last three Price to FCF figures came in at 63.65 (Q2 2026), 41.84 (Q1 2026), and 47.43 (Q4 2025), per Business Quant data.